Kindred Healthcare, Inc. (NYSE:KND)‘s stock had its “buy” rating reissued by Barclays PLC in a research report issued on Sunday, May 7th. They currently have a $13.00 target price on the health services provider’s stock, up from their prior target price of $11.00. Barclays PLC’s target price suggests a potential upside of 25.00% from the stock’s previous close.
A number of other analysts also recently weighed in on the company. Royal Bank of Canada reiterated a “hold” rating and set a $10.00 price target on shares of Kindred Healthcare in a report on Friday, May 5th. Zacks Investment Research downgraded Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Friday, May 5th. Finally, Mizuho raised their target price on Kindred Healthcare from $5.00 to $8.50 and gave the company a “neutral” rating in a research note on Tuesday, February 28th. Four research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $10.44.
Shares of Kindred Healthcare (KND) opened at 10.40 on Friday. The firm’s market capitalization is $890.58 million. The company’s 50 day moving average price is $9.86 and its 200 day moving average price is $8.26. Kindred Healthcare has a 52-week low of $5.65 and a 52-week high of $12.84.
Kindred Healthcare (NYSE:KND) last announced its earnings results on Wednesday, May 3rd. The health services provider reported $0.04 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.04. The business had revenue of $1.77 billion during the quarter, compared to analyst estimates of $1.78 billion. Kindred Healthcare had a negative return on equity of 3.05% and a net margin of 0.50%. Analysts forecast that Kindred Healthcare will post $0.53 earnings per share for the current year. A number of institutional investors have recently made changes to their positions in KND. Stevens Capital Management LP acquired a new position in shares of Kindred Healthcare during the third quarter valued at $246,000. Rhumbline Advisers boosted its position in shares of Kindred Healthcare by 4.6% in the third quarter. Rhumbline Advisers now owns 135,442 shares of the health services provider’s stock valued at $1,384,000 after buying an additional 5,965 shares during the last quarter. Teachers Advisors LLC boosted its position in shares of Kindred Healthcare by 14.7% in the third quarter. Teachers Advisors LLC now owns 1,083,835 shares of the health services provider’s stock valued at $11,077,000 after buying an additional 138,752 shares during the last quarter. BlackRock Fund Advisors boosted its position in shares of Kindred Healthcare by 8.2% in the third quarter. BlackRock Fund Advisors now owns 6,465,561 shares of the health services provider’s stock valued at $66,078,000 after buying an additional 489,417 shares during the last quarter. Finally, BlackRock Inc. boosted its position in shares of Kindred Healthcare by 2.7% in the third quarter. BlackRock Inc. now owns 27,266 shares of the health services provider’s stock valued at $279,000 after buying an additional 722 shares during the last quarter. 94.84% of the stock is currently owned by institutional investors and hedge funds.
Receive News & Ratings for Kindred Healthcare Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Kindred Healthcare Inc. and related companies with our FREE daily email newsletter.